drugset / Trial / NCT03260556
Pirfenidone for Progressive Fibrotic Sarcoidosis
Phase 4
Unknown
60 enrolled
University of Cincinnati
Royal Brompton & Harefield NHS Foundation Trust · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Study comparing pirfenidone versus placebo for patients with advanced fibrotic sarcoidosis
Timeline
- Start
- 2017-09-27
- Primary completion
- 2019-12-31
- Completion
- 2020-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pirfenidone | Small molecule | 801 mg | — |